(5-p-Tolyl-[1,2,4]oxadiazol-3-yl)-acetic acid ethyl ester, 95.0%, 500mg

(S)-2-Ethoxy-3-(4-hydroxy-phenyl)-propionic acid ethyl ester, 97.0%, 100mg

(S)-Methyl 5-oxopyrrolidine-2-carboxylate, 95.0%, 25g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpent-4-enoic acid, 98%, 250mg

N-Succinimidyl 6-Maleimidohexanoate [Cross-linking Reagent]>98.0%(N)5g

Double neck round bottom flasks side neck parallel, 2000 ml, 14/23, 1 Piece

Ethyl 2,6-dibromonicotinate, 95+%, 1g

tert-Butyl ((2S,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl)carbamate, 98%, 100mg

N-(4-Bromophenethyl)-2,2,2-trifluoroacetamide, 98%, 25g

(S)-4-Benzyl-thiazolidine-2-thione, 98.0%, 250mg

(R)-4-(TERT-BUTYL)-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 1g

Disposable syringe Omnifix® F Solo, 100 pieces

Methyl 4-(bromomethyl)-3-nitrobenzoate, 95.0%, 250mg